Document:

<PAGE>
Exhibit 10.1

COMPANY CONTACT:                               INVESTOR RELATIONS CONTACT:
Martin McDermut                                Lippert / Heilshorn & Associates
Senior Vice President, Chief Financial Officer Lillian Armstrong, Moriah Shilton
Email: mmcdermut@suptech.com                   Email: lillian@lhai-sf.com
(805) 690-4500                                 (415) 433-3777

                   SUPERCONDUCTOR TECHNOLOGIES INC. ANNOUNCES
                              THIRD QUARTER RESULTS
             - COMMERCIAL REVENUES INCREASED 170% TO $11.6 MILLION -
                                        -

      SANTA BARBARA, CALIF., OCTOBER 30, 2003 -- Superconductor Technologies
Inc. (Nasdaq: SCON) ("STI"), the global leader in high-temperature
superconducting (HTS) products for wireless voice and data applications, today
announced results for the third quarter and nine months ended September 27,
2003.

Total net revenues for the third quarter were $14.2 million, an increase of 26
percent compared to $11.3 million in the second quarter of 2003 and an increase
of 202 percent compared to $4.7 million for the third quarter ended September
28, 2002. Net commercial product revenues for the third quarter of 2003 were
$11.6 million, an increase of 30 percent compared to $8.9 million in the prior
quarter and an increase of 170 percent compared to $4.3 million in the third
quarter of 2002. Government and other contract revenue totaled $2.6 million
during the 2003 third quarter compared to $429,000 during the year ago period.
Approximately $949,000 of this increase is attributable to the acquisition of
Conductus, which closed in December of 2002.

The total net loss available to common stockholders for the quarter ended
September 27, 2003 was $851,000. Litigation expenses dropped to $90,000 for the
quarter. This compares to a net loss of $3.1 million, including litigation
expenses of $660,000, in the second quarter of 2003 and $5.4 million, including
litigation expenses of $674,000, for the quarter ended September 28, 2002. The
net loss during the third quarter of 2003 was $0.01 per diluted share, compared
to a net loss of $0.23 per diluted share in the same quarter of 2002. The net
loss available to common stockholders for the third quarter of 2002 included a
deemed distribution to preferred stockholders of $570,000.

"In the third quarter we signed our fourth GPA with a major U.S. wireless
carrier and received initial orders," said M. Peter Thomas, STI's president and
chief executive officer. "The third quarter tends to be seasonally slow as to
new orders. Our backlog stands at $2.0 million at the end of the quarter. We
however, have already seen a pick up in orders in the fourth quarter. We expect
this momentum to continue to build, resulting in strong growth in our orders for
the fourth quarter, which should translate into a strong entry into 2004."

"STI continues to improve its manufacturing efficiencies, and we achieved 30
percent commercial gross margins for the third quarter," continued Thomas. "This
translated to a net
<PAGE>
loss of less than $1 million, a marked improvement over the net loss of $3.1
million in the second quarter and a loss of $5.4 million in the year ago
quarter. "

For the first nine months of 2003, total net revenues increased 114 percent to
$33.0 million, vs. $15.4 million for the first nine months of 2002. Net
commercial product revenues for the first nine months of 2003 were $25.6
million, an increase of 92 percent compared to $13.3 million in the year ago
period. The company recorded $7.3 million in government and other contract
revenues for the first nine months of 2003, vs. $2.1 million for the first nine
months of 2002. Approximately $3.4 million of this increase is attributable to
the acquisition of Conductus, which closed in December of 2002. The net loss
available to common stockholders for the first nine months of 2003 was $12.3
million, including litigation expenses of $4.8 million, or $0.20 per diluted
share, vs. $18.3 million, including litigation expenses of $2.5 million, or
$0.85 per diluted share in the first nine months of 2002. The net loss available
to common stockholders for the first nine months of 2002 included a deemed
distribution to preferred stockholders of $1.8 million.

At September 27, 2003, STI had $13.1 million in cash and cash equivalents, and
$12.3 million in working capital. The total number of common shares outstanding
was 64,940,484 at September 27, 2003.

2003 FINANCIAL GUIDANCE

STI's expectations for commercial revenue growth are dependent on a relatively
stable or recovering economic environment and improved wireless carrier capital
expenditures in the remaining months of 2003. Its government revenue
expectations are dependent upon acceptance and timing of DARPA-related
contracts.

STI bases its outlook for the remainder of 2003 on increasing market acceptance,
especially among target customers. STI expects fourth quarter total net revenues
in the range of $13 to $17 million. STI expects to be profitable in Q4 if its
revenues are near the high end of this range. STI's full year 2003 total net
revenues are forecasted to be between $46 and $50 million.

Investors are cautioned the guidance above constitutes a forward-looking
statement which is made with reliance upon the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Risks associated with this and
other forward-looking statements included in this press release are detailed
below, and in STI's SEC filings.

INVESTOR CONFERENCE CALL

STI will host an investor conference call today at 2:00 p.m. pacific time,
October 30, 2003. The call will be accessible live by dialing 800-572-9829. A
48-hour replay will be available by dialing 800-642-1687, pass code 3299182. The
call will also be simultaneously webcast and available on STI's web site at
http://www.suptech.com.
<PAGE>
ABOUT SUPERCONDUCTOR TECHNOLOGIES INC.

Superconductor Technologies Inc., headquartered in Santa Barbara, CA, is the
global leader in developing, manufacturing, and marketing superconducting
products for wireless networks. STI's SuperLink(TM) Solutions are proven to
increase capacity utilization, lower dropped and blocked calls, extend coverage,
and enable higher wireless transmission data rates. SuperLink(TM) Rx, the
company's flagship product, incorporates patented high-temperature
superconductor (HTS) technology to create a cryogenic receiver front-end (CRFE)
used by wireless operators to enhance network performance while reducing capital
and operating costs.

More than 3,400 SuperLink Rx systems have been shipped worldwide, logging in
excess of 35 million hours of cumulative operation. In 2002 and 2003, STI was
named to Deloitte & Touche's prestigious Los Angeles Technology Fast 50 program,
a ranking of the 50 fastest-growing technology companies in the Los Angeles
area.

SuperLink is a trademark of Superconductor Technologies Inc. in the United
States and in other countries. For information about STI, please visit
www.suptech.com.

SAFE HARBOR STATEMENT

The press release contains forward-looking statements made in reliance upon the
safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, but are not limited to, STI's views on
future profitability, revenues, market growth, capital requirements and new
product introductions, and are generally identified by phrases such as "thinks,"
"anticipates," "believes," "estimates," "expects," "intends," "plans," "goals"
and similar words. Forward-looking statements are not guarantees of future
performance and are inherently subject to uncertainties and other factors which
could cause actual results to differ materially from the forward-looking
statements. These factors and uncertainties include: STI's ability to expand its
operations to meet anticipated product demands; the ability of STI's products to
achieve anticipated benefits for its customers; the anticipated growth of STI's
target markets; unanticipated delays in shipments to customers; and STI's
ability to achieve profitability. STI refers interested persons to its most
recent Annual Report on Form 10-K and its other SEC filings for a description of
additional uncertainties and factors that may affect forward-looking statements.
Forward-looking statements are based on information presently available to
senior management, and STI has not assumed any duty to update any
forward-looking statements.

                              - Tables to Follow -
<PAGE>
                        SUPERCONDUCTOR TECHNOLOGIES INC.

                      CONSOLIDATED STATEMENT OF OPERATIONS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                      THREE MONTHS ENDED                              NINE MONTHS ENDED
                                              -----------------------------------           -----------------------------------
                                             Sept., 28, 2002        Sept., 27, 2003        Sept., 28, 2002        Sept., 27, 2003
                                              ------------           ------------           ------------           ------------
<S>                                          <C>                    <C>                    <C>                    <C>
Net revenues:
     Net commercial product revenues          $  4,310,000           $ 11,570,000           $ 13,292,000           $ 25,630,000
     Government and other contract revenues        429,000              2,586,000              2,123,000              7,328,000
     Sub license royalties                              --                     --                 10,000                 41,000
                                              ------------           ------------           ------------           ------------
          Total net revenues                     4,739,000             14,156,000             15,425,000             32,999,000
Costs and expenses:
     Cost of commercial product revenues         4,715,000              8,150,000             15,089,000             19,450,000
     Contract research and development             316,000              1,728,000              1,515,000              4,661,000
     Other research and development              1,230,000                985,000              3,951,000              4,302,000
     Selling, general and administrative         3,336,000              4,052,000             11,592,000             16,614,000
                                              ------------           ------------           ------------           ------------
          Total costs and expenses               9,597,000             14,915,000             32,147,000             45,027,000
                                              ------------           ------------           ------------           ------------
Loss from operations                            (4,858,000)              (759,000)           (16,722,000)           (12,028,000)
     Interest income                                51,000                 44,000                198,000                147,000
     Interest expense                              (20,000)              (136,000)               (64,000)              (374,000)
                                              ------------           ------------           ------------           ------------
          Net loss                              (4,827,000)              (851,000)           (16,588,000)           (12,255,000)
Less:
       Deemed distribution attributable to
the preferred stock beneficial conversion
feature                                           (570,000)                    --             (1,756,000)                    --
                                              ------------           ------------           ------------           ------------
Net loss available to common stockholders     ($ 5,397,000)          ($   851,000)          ($18,344,000)          ($12,255,000)
                                              ============           ============           ============           ============
Basic and diluted loss per common share       ($      0.23)          ($      0.01)          ($      0.85)          ($      0.20)
                                              ============           ============           ============           ============
Weighted average number of common shares
outstanding                                     23,043,009             64,939,896             21,708,872             61,623,747
                                              ============           ============           ============           ============
</TABLE>
                        SUPERCONDUCTOR TECHNOLOGIES INC.

                 CONSOLIDATED SUMMARY BALANCE SHEET INFORMATION

<TABLE>
<CAPTION>
                                 DECEMBER 31, 2002    SEPTEMBER 27, 2003
                                    -----------          -----------
                                                          UNAUDITED
<S>                              <C>                  <C>
Cash and cash equivalents           $18,191,000          $13,115,000
Total current assets                 28,498,000           27,125,000
Total assets                         65,326,000           64,485,000
Total current liabilities            11,995,000           14,794,000
Long term liabilities                 3,807,000            2,266,000
Total liabilities                    15,802,000           17,060,000
Total stockholders' equity           49,524,000           47,425,000
</TABLE>

                                       ###<PAGE>

                                                                    EXHIBIT 10.1

                               INDEMNITY AGREEMENT

         This Indemnity Agreement, dated as of   ______________, 2003, is made
by and between SciClone Pharmaceuticals, Inc., a Delaware corporation (the
"COMPANY"), and [Indemnitee's Printed Name] (the "INDEMNITEE").

                                    RECITALS

         A.       The Company is aware that competent and experienced persons
are increasingly reluctant to serve as directors, officers or agents of
corporations unless they are protected by comprehensive liability insurance or
indemnification, due to increased exposure to litigation costs and risks
resulting from their service to such corporations, and due to the fact that the
exposure frequently bears no reasonable relationship to the compensation of such
directors, officers and other agents.

         B.       The statutes and judicial decisions regarding the duties of
directors and officers are often difficult to apply, ambiguous, or conflicting,
and therefore fail to provide such directors, officers and agents with adequate,
reliable knowledge of legal risks to which they are exposed or information
regarding the proper course of action to take.

         C.       Plaintiffs often seek damages in such large amounts and the
costs of litigation may be so enormous (whether or not the case is meritorious),
that the defense and/or settlement of such litigation is often beyond the
personal resources of directors, officers and other agents.

         D.       The Company believes that it is unfair for its directors,
officers and agents and the directors, officers and agents of its subsidiaries
to assume the risk of huge judgments and other expenses which may occur in cases
in which the director, officer or agent received no personal profit and in cases
where the director, officer or agent was not culpable.

         E.       The Company recognizes that the issues in controversy in
litigation against a director, officer or agent of a corporation such as the
Company or its subsidiaries are often related to the knowledge, motives and
intent of such director, officer or agent, that he is usually the only witness
with knowledge of the essential facts and exculpating circumstances regarding
such matters, and that the long period of time which usually elapses before the
trial or other disposition of such litigation often extends beyond the time that
the director, officer or agent can reasonably recall such matters; and may
extend beyond the normal time for retirement for such director, officer or agent
with the result that he, after retirement or in the event of his death, his
spouse, heirs, executors or administrators, may be faced with limited ability
and undue hardship in maintaining an adequate defense, which may discourage such
a director, officer or agent from serving in that position.

         F.       Based upon their experience as business managers, the Board of
Directors of the Company (the "BOARD") has concluded that, to retain and attract
talented and experienced individuals to serve as directors, officers and agents
of the Company and its subsidiaries and to encourage such individuals to take
the business risks necessary for the success of the Company and its
subsidiaries, it is necessary for the Company to contractually indemnify its
directors, officers and agents and the directors, officers and agents of its
subsidiaries, and to assume for

                                       1
<PAGE>

itself maximum liability for expenses and damages in connection with claims
against such directors, officers and agents in connection with their service to
the Company and its subsidiaries, and has further concluded that the failure to
provide such contractual indemnification could result in great harm to the
Company and its subsidiaries and the Company's stockholders.

         G.       Section 145 of the General Corporation Law of Delaware, under
which the Company is organized ("SECTION 145"), empowers the Company to
indemnify its directors, officers, employees and agents by agreement and to
indemnify persons who serve, at the request of the Company, as the directors,
officers, employees or agents of other corporations or enterprises, and
expressly provides that the indemnification provided by Section 145 is not
exclusive.

         H.       The Company desires and has requested the Indemnitee to serve
or continue to serve as a director, officer or agent of the Company and/or one
or more subsidiaries of the Company free from undue concern for claims for
damages arising out of or related to such services to the Company and/or one or
more subsidiaries of the Company.

         I.       Indemnitee is willing to serve, or to continue to serve, the
Company and/or one or more subsidiaries of the Company, provided that he is
furnished the indemnity provided for herein.

                                    AGREEMENT

         NOW, THEREFORE, the parties hereto, intending to be legally bound,
hereby agree as follows:

         1.       Definitions.

                  (a) Agent. For the purposes of this Agreement, "agent" of the
Company means any person who is or was a director, officer, employee or other
agent of the Company or a subsidiary of the Company; or is or was serving at the
request of, for the convenience of, or to represent the interests of the Company
or a subsidiary of the Company as a director, officer, employee or agent of
another foreign or domestic corporation, partnership, joint venture, trust or
other enterprise; or was a director, officer, employee or agent of a foreign or
domestic corporation which was a predecessor corporation of the Company or a
subsidiary of the Company, or was a director, officer, employee or agent of
another enterprise at the request of, for the convenience of, or to represent
the interests of such predecessor corporation.

                  (b) Expenses. For purposes of this Agreement, "expenses"
include all out-of-pocket costs of any type or nature whatsoever (including,
without limitation, all attorneys' fees and related disbursements), actually and
reasonably incurred by the Indemnitee in connection with either the
investigation, defense or appeal of a proceeding or establishing or enforcing a
right to indemnification under this Agreement or Section 145 or otherwise;
provided, however, that "expenses" shall not include any judgments, fines, ERISA
excise taxes or penalties, or amounts paid in settlement of a proceeding.

                                       2
<PAGE>

                  (c) Proceeding. For the purposes of this Agreement,
"proceeding" means any threatened, pending, or completed action, suit or other
proceeding, whether civil, criminal, administrative, or investigative.

                  (d) Subsidiary. For purposes of this Agreement, "subsidiary"
means any corporation of which more than 50% of the outstanding voting
securities is owned directly or indirectly by the Company, by the Company and
one or more other subsidiaries, or by one or more other subsidiaries.

         2.       Agreement to Serve. The Indemnitee agrees to serve and/or
continue to serve as agent of the Company, at its will (or under separate
agreement, if such agreement exists), in the capacity Indemnitee currently
serves as an agent of the Company, so long as he is duly appointed or elected
and qualified in accordance with the applicable provisions of the Bylaws of the
Company or any subsidiary of the Company or until such time as he tenders his
resignation in writing; provided, however, that nothing contained in this
Agreement is intended to create any right to continued employment by Indemnitee.

         3.       Liability Insurance.

                  (a)      Maintenance of D&O Insurance. The Company hereby
covenants and agrees that, so long as the Indemnitee shall continue to serve as
an agent of the Company and thereafter so long as the Indemnitee shall be
subject to any possible proceeding by reason of the fact that the Indemnitee was
an agent of the Company, the Company, subject to Section 3(c), shall promptly
obtain and maintain in full force and effect directors' and officers' liability
insurance ("D&O INSURANCE") in reasonable amounts from established and reputable
insurers.

                  (b)      Rights and Benefits. In all policies of D&O
Insurance, the Indemnitee shall be named as an insured in such a manner as to
provide the Indemnitee the same rights and benefits as are accorded to the most
favorably insured of the Company's directors, if the Indemnitee is a director;
or of the Company's officers, if the Indemnitee is not a director of the Company
but is an officer; or of the Company's key employees, if the Indemnitee is not a
director or officer but is a key employee.

                  (c)      Limitation on Required Maintenance of D&O Insurance.
Notwithstanding the foregoing, the Company shall have no obligation to obtain or
maintain D&O Insurance if the Company determines in good faith that such
insurance is not reasonably available, the premium costs for such insurance are
disproportionate to the amount of coverage provided, the coverage provided by
such insurance is limited by exclusions so as to provide an insufficient
benefit, or the Indemnitee is covered by similar insurance maintained by a
subsidiary of the Company.

         4.       Mandatory Indemnification. Subject to Section 9 below, the
Company shall indemnify the Indemnitee as follows:

                  (a)      Successful Defense. To the extent the Indemnitee has
been successful on the merits or otherwise in defense of any proceeding
(including, without limitation, an action by or in the right of the Company) to
which the Indemnitee was a party by reason of the fact that he is or was an
agent of the Company at any time, against all expenses of any type whatsoever

                                       3
<PAGE>

actually and reasonably incurred by him in connection with the investigation,
defense or appeal of such proceeding.

                  (b)      Third Party Actions. If the Indemnitee is a person
who was or is a party or is threatened to be made a party to any proceeding
(other than an action by or in the right of the Company) by reason of the fact
that he is or was an agent of the Company, or by reason of anything done or not
done by him in any such capacity, the Company shall indemnify the Indemnitee
against any and all expenses and liabilities of any type whatsoever (including,
but not limited to, judgments, fines, ERISA excise taxes and penalties, and
amounts paid in settlement) actually and reasonably incurred by him in
connection with the investigation, defense, settlement or appeal of such
proceeding, provided the Indemnitee acted in good faith and in a manner he
reasonably believed to be in or not opposed to the best interests of the Company
and its stockholders, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe his conduct was unlawful.

                  (c)      Derivative Actions. If the Indemnitee is a person who
was or is a party or is threatened to be made a party to any proceeding by or in
the right of the Company by reason of the fact that he is or was an agent of the
Company, or by reason of anything done or not done by him in any such capacity,
the Company shall indemnify the Indemnitee against all expenses actually and
reasonably incurred by him in connection with the investigation, defense,
settlement, or appeal of such proceeding, provided the Indemnitee acted in good
faith and in a manner he reasonably believed to be in or not opposed to the best
interests of the Company and its stockholders; except that no indemnification
under this subsection 4(c) shall be made in respect to any claim, issue or
matter as to which such person shall have been finally adjudged to be liable to
the Company by a court of competent jurisdiction unless and only to the extent
that the court in which such proceeding was brought shall determine upon
application that, despite the adjudication of liability but in view of all the
circumstances of the case, such person is fairly and reasonably entitled to
indemnity for such amounts which the court shall deem proper.

                  (d)      Actions where Indemnitee is Deceased. If the
Indemnitee is a person who was or is a party or is threatened to be made a party
to any proceeding by reason of the fact that he is or was an agent of the
Company, or by reason of anything done or not done by him in any such capacity,
and if prior to, during the pendency of after completion of such proceeding
Indemnitee becomes deceased, the Company shall indemnify the Indemnitee's heirs,
executors and administrators against any and all expenses and liabilities of any
type whatsoever (including, but not limited to, judgments, fines, ERISA excise
taxes and penalties, and amounts paid in settlement) actually and reasonably
incurred to the extent Indemnitee would have been entitled to indemnification
pursuant to Sections 4(a), 4(b), or 4(c) above were Indemnitee still alive.

                  (e)      Notwithstanding the foregoing, the Company shall not
be obligated to indemnify the Indemnitee for expenses or liabilities of any type
whatsoever (including, but not limited to, judgments, fines, ERISA excise taxes
and penalties, and amounts paid in settlement) for which payment is actually
made to or on behalf of Indemnitee under a valid and collectible insurance
policy of D&O Insurance, or under a valid and enforceable indemnity clause,
by-law or agreement.

                                       4
<PAGE>

         5.       Partial Indemnification. If the Indemnitee is entitled under
any provision of this Agreement to indemnification by the Company for some or a
portion of any expenses or liabilities of any type whatsoever (including, but
not limited to, judgments, fines, ERISA excise taxes and penalties, and amounts
paid in settlement) incurred by him in the investigation, defense, settlement or
appeal of a proceeding, but not entitled, however, to indemnification for all of
the total amount hereof, the Company shall nevertheless indemnify the Indemnitee
for such total amount except as to the portion hereof to which the Indemnitee is
not entitled.

         6.       Mandatory Advancement of Expenses. Subject to Section 8(a)
below, the Company shall advance all expenses incurred by the Indemnitee in
connection with the investigation, defense, settlement or appeal of any
proceeding to which the Indemnitee is a party or is threatened to be made a
party by reason of the fact that the Indemnitee is or was an agent of the
Company. Indemnitee hereby undertakes to repay such amounts advanced only if,
and to the extent that, it shall be determined ultimately that the Indemnitee is
not entitled to be indemnified by the Company as authorized hereby. The advances
to be made hereunder shall be paid by the Company to the Indemnitee within
twenty (20) days following delivery of a written request therefor by the
Indemnitee to the Company. In the event that the Company fails to pay expenses
as incurred by the Indemnitee as required by this paragraph, Indemnitee may seek
mandatory injunctive relief from any court having jurisdiction to require the
Company to pay expenses as set forth in this paragraph. If Indemnitee seeks
mandatory injunctive relief pursuant to this paragraph, it shall not be a
defense to enforcement of the Company's obligations set forth in this paragraph
that Indemnitee has an adequate remedy at law for damages.

         7.       Notice and Other Indemnification Procedures.

                  (a)      Promptly after receipt by the Indemnitee of notice of
the commencement of or the threat of commencement of any proceeding, the
Indemnitee shall, if the Indemnitee believes that indemnification with respect
thereto may be sought from the Company under this Agreement, notify the Company
of the commencement or threat of commencement thereof.

                  (b)      If, at the time of the receipt of a notice of the
commencement of a proceeding pursuant to Section 7(a) hereof, the Company has
D&O Insurance in effect, the Company shall give prompt notice of the
commencement of such proceeding to the insurers in accordance with the
procedures set forth in the respective policies. The Company shall thereafter
take all necessary or desirable action to cause such insurers to pay, on behalf
of the Indemnitee, all amounts payable as a result of such proceeding in
accordance with the terms of such policies.

                  (c)      In the event the Company shall be obligated to pay
the expenses of any proceeding against the Indemnitee, the Company, if
appropriate, shall be entitled to assume the defense of such proceeding, with
counsel approved by the Indemnitee, upon the delivery to the Indemnitee of
written notice of its election so to do. After delivery of such notice, approval
of such counsel by the Indemnitee and the retention of such counsel by the
Company, the Company will not be liable to the Indemnitee under this Agreement
for any fees of counsel subsequently incurred by the Indemnitee with respect to
the same proceeding, provided that (i) the Indemnitee shall have the right to
employ his counsel in any such proceeding at the Indemnitee's expense; and (ii)
if (A) the employment of counsel by the Indemnitee has been previously
authorized by the Company, (B) the Indemnitee shall have reasonably concluded
that there may be a conflict of

                                       5
<PAGE>

interest between the Company and the Indemnitee in the conduct of any such
defense, or (C) the Company shall not, in fact, have employed counsel to assume
the defense of such proceeding, then the fees and expenses of Indemnitee's
counsel shall be at the expense of the Company.

         8.       Exceptions. Any other provision herein to the contrary
notwithstanding, the Company shall not be obligated pursuant to the terms of
this Agreement:

                  (a)      Claims Initiated by Indemnitee. To indemnify or
advance expenses to the Indemnitee with respect to proceedings or claims
initiated or brought voluntarily by the Indemnitee and not by way of defense,
unless (i) such indemnification is expressly required to be made by law, (ii)
the proceeding was authorized by the Board, (iii) such indemnification is
provided by the Company, in its sole discretion, pursuant to the powers vested
in the Company under the General Corporation Law of Delaware or (iv) the
proceeding is brought to establish or enforce a right to indemnification under
this Agreement or any other statute or law or otherwise as required under
Section 145;

                  (b)      Lack of Good Faith. To indemnify the Indemnitee for
any expenses incurred by the Indemnitee with respect to any proceeding
instituted by the Indemnitee to enforce or interpret this Agreement, if a court
of competent jurisdiction determines that each of the material assertions made
by the Indemnitee in such proceeding was not made in good faith or was
frivolous; or

                  (c)      Unauthorized Settlements. To indemnify the Indemnitee
under this Agreement for any amounts paid in settlement of a proceeding unless
the Company consents to such settlement, which consent shall not be unreasonably
withheld.

         9.       Non-exclusivity. The provisions for indemnification and
advancement of expenses set forth in this Agreement shall not be deemed
exclusive of any other rights which the Indemnitee may have under any provision
of law, the Company's Certificate of Incorporation or Bylaws, the vote of the
Company's stockholders or disinterested directors, other agreements, or
otherwise, both as to action in his official capacity and to action in another
capacity while occupying his position as an agent of the Company, and the
Indemnitee's rights hereunder shall continue after the Indemnitee has ceased
acting as an agent of the Company and shall inure to the benefit of the heirs,
executors and administrators of the Indemnitee.

         10.      Enforcement. Any right to indemnification or advances granted
by this Agreement to Indemnitee shall be enforceable by or on behalf of
Indemnitee in any court of competent jurisdiction if (i) the claim for
indemnification or advances is denied, in whole or in part, or (ii) no
disposition of such claim is made within ninety (90) days of request therefor.
Indemnitee, in such enforcement action, if successful in whole or in part, shall
be entitled to be paid also the expense of prosecuting his claim. It shall be a
defense to any action for which a claim for indemnification is made under this
Agreement (other than an action brought to enforce a claim for expenses pursuant
to Section 6 hereof, provided that the required undertaking has been tendered to
the Company) that Indemnitee is not entitled to indemnification because of the
limitations set forth in Sections 4 and 8 hereof. Neither the failure of the
Corporation (including its Board of Directors or its stockholders) to have made
a determination prior to the commencement of such enforcement action that
indemnification of Indemnitee is proper in the

                                       6
<PAGE>

circumstances, nor an actual determination by the Company (including its Board
of Directors or its stockholders) that such indemnification is improper, shall
be a defense to the action or create a presumption that Indemnitee is not
entitled to indemnification under this Agreement or otherwise.

         11.      Subrogation. In the event the Company is obligated to make a
payment under this Agreement, the Company shall be subrogated to the extent of
such payment to all of the rights of recovery under an insurance policy or any
other indemnity agreement covering the Indemnitee, who shall execute all
documents required and shall do all acts that may be necessary to secure such
rights and to enable the Company effectively to bring suit to enforce such
rights.

         12.      Survival of Rights.

                  (a)      All agreements and obligations of the Company
contained herein shall continue during the period Indemnitee is an agent of the
Company and shall continue thereafter so long as Indemnitee shall be subject to
any possible claim or threatened, pending or completed action, suit or
proceeding, whether civil, criminal, arbitrational, administrative or
investigative, by reason of the fact that Indemnitee was serving in the capacity
referred to herein.

                  (b)      The Company shall require any successor to the
Company (whether direct or indirect, by purchase, merger, consolidation or
otherwise) to all or substantially all of the business or assets of the Company,
expressly to assume and agree to perform this Agreement in the same manner and
to the same extent that the Company would be required to perform if no such
succession had taken place.

         13.      Interpretation of Agreement. It is understood that the parties
hereto intend this Agreement to be interpreted and enforced so as to provide
indemnification to the Indemnitee to the fullest extent permitted by law
including those circumstances in which indemnification would otherwise be
discretionary.

         14.      Severability. If any provision or provisions of this Agreement
shall be held to be invalid, illegal or unenforceable for any reason whatsoever,
(i) the validity, legality and enforceability of the remaining provisions of the
Agreement (including without limitation, all portions of any paragraphs of this
Agreement containing any such provision held to be invalid, illegal or
unenforceable, that are not themselves invalid, illegal or unenforceable) shall
not in any way be affected or impaired thereby, and (ii) to the fullest extent
possible, the provisions of this Agreement (including, without limitation, all
portions of any paragraph of this Agreement containing any such provision held
to be invalid, illegal or unenforceable, that are not themselves invalid,
illegal or unenforceable) shall be construed so as to give effect to the intent
manifested by the provision held invalid, illegal or unenforceable and to give
effect to Section 13 hereof.

         15.      Modification and Waiver. No supplement, modification or
amendment of this Agreement shall be binding unless executed in writing by both
of the parties hereto. No waiver of any of the provisions of this Agreement
shall be deemed or shall constitute a waiver of any other provisions hereof
(whether or not similar) nor shall such waiver constitute a continuing waiver.

                                       7
<PAGE>

         16.      Notice. All notices, requests, demands and other
communications under this Agreement shall be in writing and shall be deemed duly
given (i) if delivered by hand and receipted for by the party addressee or (ii)
if mailed by certified or registered mail with postage prepaid, on the third
business day after the mailing date. Addresses for notice to either party are as
shown on the signature page of this Agreement, or as subsequently modified by
written notice.

         17.      Governing Law. This Agreement shall be governed exclusively by
and construed according to the laws of the State of Delaware as applied to
contracts between Delaware residents entered into and to be performed entirely
within Delaware.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       8
<PAGE>

         The parties hereto have entered into this Indemnity Agreement effective
as of the date first above written.

                                 SCICLONE PHARMACEUTICALS, INC.
                                 a Delaware corporation

                                 By:____________________________________________

                                 Title:_________________________________________

                                 Address: 901 Mariner's Island Blvd., Suite 205
                                          San Mateo, California 94404

                                 Attn: Richard A. Waldron, Secretary

                                 INDEMNITEE:

                                 _______________________________________________
                                 [Indemnitee's Printed Name]

                                 Address_______________________________________

                                 _______________________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]